This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Point Of Care Testing Market And Forecast To 2016: Global Analysis

4.3 Lipid Panel/Cholesterol Testing Market & Forecast

4.4 Blood Coagulation Testing Market & Forecast

4.5 Infectious Disease Testing Market & Forecast

4.6 Urinalysis Testing Market & Forecast

4.7 Drug of Abuse Testing Market & Forecast

4.8 Fecal Occult Blood Testing Market & Forecast

4.9 Pregnancy & Fertility Testing Market & Forecast

4.10 Tumor Marker Testing Market & Forecast

5. Merger & Acquisition, Distribution Agreement, Licensing Deals in Point of Care Testing Market

5.1 Merger & Acquisition in Point of Care Testing Market

5.2 Merger & Acquisition in Major Hospital & Clinics

5.3 Distribution Agreement in Point of Care Testing Market

5.4 Licensing Deals in Point of Care Testing Market

6. Growth Drivers of the Point of Care Testing Market

6.1 Increase in Chronic Diseases Driving Demand for Point of Care Testing Market

6.2 Continued Expansion of Point Of Care Including Self Testing6.2.1 The Promise of Point-of-Care Testing6.2.2 Future of Point of Care Testing – The 'Worried Well'6.2.3 Theranostics – Companion Diagnostics6.2.4 Hub and Spoke6.2.5 Education

6.3 New Evolution Enhances Point of Care Testing Market

6.3.1 Point of Care Testing (POCT)

6.3.2 On the Market

6.3.3 Expanding Test Menu

6.3.4 Diabetes Tests

6.3.5 Chronic Kidney Disease

6.3.6 Oral Specimens

6.4 Point of Care Testing: A Step to the Future6.4.1 Paradigm Shifts6.4.2 Why Consider POCT? 6.4.3 The Future

7. Challenges of the Point of Care Testing Market

7.1 Manufacturing Obstacles in POC Testing Product Development7.1.1 Avoiding Too Much, Too Soon7.1.2 Closely Considering Materials and Environment

7.2 Point of Care Testing (POCT) More Expensive than Testing Performed in a Centralized Laboratory

7.3 Point of Care (POC) Testing Barriers in Low & Middle Income Countries7.3.1 Barriers to Adoption & Scale-up of POC Technologies7.3.2 Technical, Administrative & Operational Barriers of Point of Care Tests7.3.3 Health System Related Barriers of Point of Care Tests7.3.4 Economic Barriers of Point of Care Tests

3 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,678.23 -40.31 -0.23%
S&P 500 2,056.15 -4.90 -0.24%
NASDAQ 4,863.3620 -13.1570 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs